Atlas Trials

Phase IV Study to Gather More Information About the Safety of ACZONE Gel, 5% in Treating Subjects With Acne Who Have G6PD Deficiency

Clinical trial NCT00243542 · COMPLETED

Trial details

NCT number
NCT00243542
Sponsor
Allergan
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Acne Vulgaris
Start date
2005-11-01
Primary completion
2006-10-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.